Development of an AP-FRET based analysis for characterizing RNA-protein interactions in myotonic dystrophy (DM1)

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Rehman, Shagufta ^a   Gladman, Jordan T ^a   Periasamy, Ammasi ^b   Sun, Yuansheng ^b   Mahadevan, Mani S ^a  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CUGBP1 PROTEIN; MBNL1 PROTEIN; MESSENGER RNA; REGULATOR PROTEIN; RNA; RNA BINDING PROTEIN; RNPH PROTEIN; UNCLASSIFIED DRUG; 3' UNTRANSLATED REGION; DMPK PROTEIN, HUMAN; MYOTONIC DYSTROPHY PROTEIN KINASE;

ACCEPTOR PHOTOBLEACHING FORSTER RESONANCE ENERGY TRANSFER; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BINDING SITE; CONTROLLED STUDY; DISEASE ACTIVITY; ENERGY TRANSFER; GENE FUNCTION; GENE IDENTIFICATION; HUMAN; HUMAN CELL; MICROSCOPY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; MOUSE; MYOTONIC DYSTROPHY; NONHUMAN; PROTEIN DETERMINATION; PROTEIN DOMAIN; PROTEIN FUNCTION; PROTEIN RNA BINDING; RNA SPLICING; 3' UNTRANSLATED REGION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETICS; METABOLISM; POLYMERASE CHAIN REACTION;

3' UNTRANSLATED REGIONS; FLUORESCENCE RESONANCE ENERGY TRANSFER; HUMANS; MYOTONIC DYSTROPHY; MYOTONIN-PROTEIN KINASE; POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA-BINDING PROTEINS;

EID: 84899762955     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0095957     Document Type: Article

References (41)

1. Sun Y, Wallrabe H, Seo SA, Periasamy A (2011) FRET microscopy in 2010: the legacy of Theodor Forster on the 100th anniversary of his birth. Chemphyschem 12: 462-474.
2. Sekar RB, Periasamy A (2003) Fluorescence resonance energy transfer (FRET) microscopy imaging of live cell protein localizations. J Cell Biol 160: 629-633. (Pubitemid 36298259)
3. Periasamy A (2001) Fluorescence resonance energy transfer microscopy: a mini review. J Biomed Opt 6: 287-291.
4. Day RN, Periasamy A, Schaufele F (2001) Fluorescence resonance energy transfer microscopy of localized protein interactions in the living cell nucleus. Methods 25: 4-18. (Pubitemid 32905284)
5. Liquori CL, Ricker K, Moseley ML, Jacobsen JF, Kress W, et al. (2001) Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 293: 864-867. (Pubitemid 32743976)
6. Ranum LP, Day JW (2004) Myotonic dystrophy: RNA pathogenesis comes into focus. Am J Hum Genet 74: 793-804. (Pubitemid 38568955)
7. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 39 end of a transcript encoding a protein kinase family member. Cell 68: 799-808.
8. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, et al. (1992) Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255: 1253-1255.
9. Davis BM, McCurrach ME, Taneja KL, Singer RH, Housman DE (1997) Expansion of a CUG trinucleotide repeat in the 39 untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci U S A 94: 7388-7393.
10. Wojciechowska M, Krzyzosiak WJ (2011) Cellular toxicity of expanded RNA repeats: focus on RNA foci. Hum Mol Genet 20: 3811-3821.
11. Miller JW, Urbinati CR, Teng-Umnuay P, Stenberg MG, Byrne BJ, et al. (2000) Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. Embo J 19: 4439-4448.
12. Timchenko LT, Miller JW, Timchenko NA, DeVore DR, Datar KV, et al. (1996) Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 24: 4407-4414. (Pubitemid 26388627)
13. Philips AV, Timchenko LT, Cooper TA (1998) Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 280: 737-741. (Pubitemid 28243348)
14. Kanadia RN, Johnstone KA, Mankodi A, Lungu C, Thornton CA, et al. (2003) A muscleblind knockout model for myotonic dystrophy. Science 302: 1978-1980. (Pubitemid 37523508)
15. Ho TH, Charlet BN, Poulos MG, Singh G, Swanson MS, et al. (2004) Muscleblind proteins regulate alternative splicing. Embo J 23: 3103-3112. (Pubitemid 39093604)
16. Mahadevan MS, Yadava RS, Yu Q, Balijepalli S, Frenzel-McCardell CD, et al. (2006) Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat Genet 38: 1066-1070. (Pubitemid 44325934)
17. Wang GS, Kearney DL, De Biasi M, Taffet G, Cooper TA (2007) Elevation of RNA-binding protein CUGBP1 is an early event in an inducible heart-specific mouse model of myotonic dystrophy. J Clin Invest 117: 2802-2811. (Pubitemid 47529611)
18. Fardaei M, Rogers MT, Thorpe HM, Larkin K, Hamshere MG, et al. (2002) Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 11: 805-814. (Pubitemid 34428648)
19. Fardaei M, Larkin K, Brook JD, Hamshere MG (2001) In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res 29: 2766-2771. (Pubitemid 32685039)
20. Mankodi A, Lin X, Blaxall BC, Swanson MS, Thornton CA (2005) Nuclear RNA foci in the heart in myotonic dystrophy. Circ Res 97: 1152-1155.
21. Jiang H, Mankodi A, Swanson MS, Moxley RT, Thornton CA (2004) Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 13: 3079-3088. (Pubitemid 40045262)
22. Mankodi A, Urbinati CR, Yuan QP, Moxley RT, Sansone V, et al. (2001) Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 10: 2165-2170. (Pubitemid 32998828)
23. Mankodi A, Logigian E, Callahan L, McClain C, White R, et al. (2000) Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 289: 1769-1773.
24. Hamshere MG, Newman EE, Alwazzan M, Athwal BS, Brook JD (1997) Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. Proc Natl Acad Sci U S A 94: 7394-7399. (Pubitemid 27345326)
25. Langlois MA, Lee NS, Rossi JJ, Puymirat J (2003) Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts. Mol Ther 7: 670-680. (Pubitemid 36626247)
26. O'Leary DA, Vargas L, Sharif O, Garcia ME, Sigal YJ, et al. HTS-Compatible Patient-Derived Cell-Based Assay to Identify Small Molecule Modulators of Aberrant Splicing in Myotonic Dystrophy Type 1. Curr Chem Genomics 4: 9-18.
27. Kenworthy AK (2001) Imaging protein-protein interactions using fluorescence resonance energy transfer microscopy. Methods 24: 289-296.
28. Kim DH, Langlois MA, Lee KB, Riggs AD, Puymirat J, et al. (2005) HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence. Nucleic Acids Res 33: 3866-3874. (Pubitemid 41418556)
29. Paul S, Dansithong W, Kim D, Rossi J, Webster NJ, et al. (2006) Interaction of muscleblind, CUG-BP1 and hnRNP H proteins in DM1-associated aberrant IR splicing. Embo J 25: 4271-4283. (Pubitemid 44435225)
30. Tiscornia G, Mahadevan MS (2000) Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol Cell 5: 959-967.
31. Kino Y, Mori D, Oma Y, Takeshita Y, Sasagawa N, et al. (2004) Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats. Hum Mol Genet 13: 495-507. (Pubitemid 38313209)
32. Kino Y, Washizu C, Oma Y, Onishi H, Nezu Y, et al. (2009) MBNL and CELF proteins regulate alternative splicing of the skeletal muscle chloride channel CLCN1. Nucleic Acids Res 37: 6477-6490.
33. Orengo JP, Chambon P, Metzger D, Mosier DR, Snipes GJ, et al. (2008) Expanded CTG repeats within the DMPK 39 UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci U S A 105: 2646-2651. (Pubitemid 351520567)
34. Pascual M, Vicente M, Monferrer L, Artero R (2006) The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing. Differentiation 74: 65-80. (Pubitemid 43376167)
35. Du H, Cline MS, Osborne RJ, Tuttle DL, Clark TA, et al. (2010) Aberrant alternative splicing and extracellular matrix gene expression in mouse models of myotonic dystrophy. Nat Struct Mol Biol 17: 187-193.
36. Kimura T, Nakamori M, Lueck JD, Pouliquin P, Aoike F, et al. (2005) Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2 +-ATPase in myotonic dystrophy type 1. Hum Mol Genet 14: 2189-2200. (Pubitemid 41418018)
37. Grammatikakis I, Goo YH, Echeverria GV, Cooper TA (2011) Identification of MBNL1 and MBNL3 domains required for splicing activation and repression. Nucleic Acids Res 39: 2769-2780.
38. de Haro M, Al-Ramahi I, De Gouyon B, Ukani L, Rosa A, et al. (2006) MBNL1 and CUGBP1 modify expanded CUG-induced toxicity in a Drosophila model of myotonic dystrophy type 1. Hum Mol Genet 15: 2138-2145. (Pubitemid 43923403)
39. Machuca-Tzili L, Thorpe H, Robinson TE, Sewry C, Brook JD (2006) Flies deficient in Muscleblind protein model features of myotonic dystrophy with altered splice forms of Z-band associated transcripts. Hum Genet 120: 487-499. (Pubitemid 44669783)
40. Tran H, Gourrier N, Lemercier-Neuillet C, Dhaenens CM, Vautrin A, et al. Analysis of exonic regions involved in nuclear localization, splicing activity, and dimerization of Muscleblind-like-1 isoforms. J Biol Chem 286: 16435-16446.
41. Paul S, Dansithong W, Jog SP, Holt I, Mittal S, et al. (2011) Expanded CUG repeats Dysregulate RNA splicing by altering the stoichiometry of the muscleblind 1 complex. J Biol Chem 286: 38427-38438.